Morgan Stanley’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $29.7K | Buy |
4,583
+1,216
| +36% | +$11.2K | ﹤0.01% | 6689 |
|
|
2026
Q1 | $34.5K | Buy |
3,367
+1,098
| +48% | +$9.24K | ﹤0.01% | 6548 |
|
|
2025
Q4 | $14.3K | Buy |
2,269
+2,267
| +113,350% | +$12.4K | ﹤0.01% | 6801 |
|
|
2025
Q3 | $6 | Sell |
2
-107
| -98% | -$277 | ﹤0.01% | 8117 |
|
|
2025
Q2 | $207 | Hold |
109
| – | – | ﹤0.01% | 7568 |
|
|
2025
Q1 | $159 | Hold |
109
| – | – | ﹤0.01% | 7498 |
|
|
2024
Q4 | $202 | Hold |
109
| – | – | ﹤0.01% | 7413 |
|
|
2024
Q3 | $258 | Buy |
109
+107
| +5,350% | +$274 | ﹤0.01% | 7360 |
|
|
2024
Q2 | $6 | Sell |
2
-424
| -100% | -$1.21K | ﹤0.01% | 7802 |
|
|
2024
Q1 | $1.78K | Buy |
426
+424
| +21,200% | +$1.53K | ﹤0.01% | 7090 |
|
|
2023
Q4 | $6 | Hold |
2
| – | – | ﹤0.01% | 7772 |
|
|
2023
Q3 | $6 | Hold |
2
| – | – | ﹤0.01% | 7574 |
|
|
2023
Q2 | $2 | Hold |
2
| – | – | ﹤0.01% | 7634 |
|
|
2023
Q1 | $3 | Sell |
2
-12
| -86% | -$28 | ﹤0.01% | 7687 |
|
|
2022
Q4 | $17 | Buy |
14
+13
| +1,300% | +$34 | ﹤0.01% | 7780 |
|
|
2022
Q3 | $0 | Sell |
1
-1,070
| -100% | -$4.31K | ﹤0.01% | 7695 |
|
|
2022
Q2 | $4K | Hold |
1,071
| – | – | ﹤0.01% | 7439 |
|
|
2022
Q1 | $5K | Sell |
1,071
-14
| -1% | -$72 | ﹤0.01% | 7572 |
|
|
2021
Q4 | $6K | Sell |
1,085
-58
| -5% | -$242 | ﹤0.01% | 7592 |
|
|
2021
Q3 | $4K | Sell |
1,143
-849
| -43% | -$3.23K | ﹤0.01% | 7533 |
|
|
2021
Q2 | $8K | Hold |
1,992
| – | – | ﹤0.01% | 7291 |
|
|
2021
Q1 | $10K | Hold |
1,992
| – | – | ﹤0.01% | 6927 |
|
|
2020
Q4 | $6K | Hold |
1,992
| – | – | ﹤0.01% | 6735 |
|
|
2020
Q3 | $6K | Hold |
1,992
| – | – | ﹤0.01% | 6400 |
|
|
2020
Q2 | $8K | Hold |
1,992
| – | – | ﹤0.01% | 6209 |
|
|
2020
Q1 | $6K | Hold |
1,992
| – | – | ﹤0.01% | 6144 |
|
|
2019
Q4 | $6K | Sell |
1,992
-235
| -11% | -$946 | ﹤0.01% | 6365 |
|
|
2019
Q3 | $8K | Buy |
2,227
+2,084
| +1,457% | +$8.2K | ﹤0.01% | 6264 |
|
|
2019
Q2 | $1K | Buy |
143
+72
| +101% | +$276 | ﹤0.01% | 6514 |
|
|
2019
Q1 | $0 | Sell |
71
-34
| -32% | -$129 | ﹤0.01% | 6586 |
|
|
2018
Q4 | $0 | Buy |
+105
| New | +$512 | ﹤0.01% | 6589 |
|
|
2018
Q3 | – | Sell |
-5
| Closed | – | – | 6703 |
|
|
2018
Q2 | $0 | Buy |
+5
| New | +$81 | ﹤0.01% | 6658 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6561 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6525 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6582 |
|
|
2016
Q3 | – | Sell |
-16
| Closed | -$3K | – | 6499 |
|
|
2016
Q2 | $3K | Hold |
16
| – | – | ﹤0.01% | 6291 |
|
|
2016
Q1 | $9K | Sell |
16
-29
| -64% | -$14.9K | ﹤0.01% | 6154 |
|
|
2015
Q4 | $25K | Buy |
45
+16
| +55% | +$12.3K | ﹤0.01% | 5958 |
|
|
2015
Q3 | $16K | Buy |
+29
| New | +$26.5K | ﹤0.01% | 6113 |
|
Other funds holding ARMP
MAM
DIG
Morgan Stanley's ARMP Position: Q2 2026 in Review
Morgan Stanley increased its Armata Pharmaceuticals (ARMP) stake by 36% in Q2 2026, buying an estimated $11.2K and bringing the position to 4,583 shares worth $29.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6689.
Morgan Stanley first reported a position in ARMP in Q3 2015 and has held it in 36 quarters since. The position peaked at $34.5K in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.
- Morgan Stanley held 4,583 shares of Armata Pharmaceuticals worth $29.7K as of Q2 2026.
- Morgan Stanley bought 1,216 Armata Pharmaceuticals shares in Q2 2026, an estimated $11.2K.
- Armata Pharmaceuticals made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6689 holding.
- Morgan Stanley first reported a position in Armata Pharmaceuticals in Q3 2015 and has held it in 36 quarters since.
- Morgan Stanley's Armata Pharmaceuticals position peaked at $34.5K in Q1 2026.
- 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.